CVR: 29829586
Secondary names: Drug Delivery Solutions ApS, Wynzora ApS, PAD Technology ApS
Previous names: TOXICELL ApS, DRUG DELIVERY SOLUTIONS ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity amounted to DKK 23,772,837.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed ved forskning, udvikling og handel indenfor biotek og anden hermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 4.8 mio. | 6.5 mio. | 25.5 mio. | 23.8 mio. | 0 | |
| 2024 | 4.4 mio. | 5.5 mio. | 18.6 mio. | 17.2 mio. | - | |
| 2023 | 7.5 mio. | 7.9 mio. | 12.4 mio. | 11.7 mio. | - | |
| 2022 | 3.6 mio. | 3.6 mio. | 4.8 mio. | 3.8 mio. | - | |
| 2021 | 8.6 mio. | 7.8 mio. | 1.2 mio. | 208 t. | - | |
| 2020 | -461 t. | -2.8 mio. | 199 t. | -57.6 mio. | - | |
| 2019 | -273 t. | -2.4 mio. | 232 t. | -54.8 mio. | - | |
| 2018 | -386 t. | -2.4 mio. | 3.4 mio. | -52.4 mio. | 0 | |
| 2017 | -7.8 mio. | -4.2 mio. | 4.6 mio. | -50.1 mio. | - | |
| 2016 | -33 mio. | -38.7 mio. | 3.2 mio. | -45.8 mio. | - | |
| 2015 | -32.2 mio. | -33 mio. | 7.2 mio. | -7.1 mio. | - | |
| 2014 | -18.3 mio. | -17.2 mio. | 5 mio. | -78.7 mio. | - | |
| 2013 | -15.5 mio. | -18.6 mio. | 422 t. | -61.4 mio. | - | |
| 2012 | -11 mio. | -11.8 mio. | 1.9 mio. | -42.8 mio. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Biomee ApS has published its annual report for 2025. Gross profit came to DKK 4,813,840, and the net result was DKK 6,548,744.
Contact info changed: new phone: 53514153 (June 3, 2026).
Biomee ApS has published its annual report for 2024. Gross profit came to DKK 4,444,339, and the net result was DKK 5,547,134.
As of May 27, 2025, Trine Ahlgreen is registered as director of biomee ApS.
As of May 27, 2025, Jesper Jørn Lange has stepped down as director of biomee ApS.
Biomee ApS has published its annual report for 2023. Gross profit came to DKK 7,518,821, and the net result was DKK 7,867,031.
Biomee ApS has published its annual report for 2022. Gross profit came to DKK 3,551,834, and the net result was DKK 3,602,319.
Biomee ApS has published its annual report for 2021. Gross profit came to DKK 8,630,918, and the net result was DKK 7,786,490.
Biomee ApS has published its annual report for 2020. Gross profit came to DKK -461,055, and the net result was DKK -2,776,006.
On March 18, 2021, the company changed its name from DRUG DELIVERY SOLUTIONS ApS to biomee ApS.
Biomee ApS has published its annual report for 2019. Gross profit came to DKK -272,730, and the net result was DKK -2,353,230.
Biomee ApS has published its annual report for 2018. Gross profit came to DKK -386,013, and the net result was DKK -2,372,896.
Biomee ApS has published its annual report for 2017. Gross profit came to DKK -7,813,359, and the net result was DKK -4,230,706.
As of December 29, 2017, MC2 Therapeutics A/S is registered as an owner of biomee ApS with an ownership share of 100%.
Biomee ApS has published its annual report for 2016. Gross profit came to DKK -33,025,329, and the net result was DKK -38,706,747.
Biomee ApS has published its annual report for 2015. Gross profit came to DKK -32,170,559, and the net result was DKK -32,989,267.
Biomee ApS has published its annual report for 2014. Gross profit came to DKK -18,319,893, and the net result was DKK -17,231,020.
Biomee ApS has published its annual report for 2013. Gross profit came to DKK -15,514,659, and the net result was DKK -18,595,390.
Biomee ApS has published its annual report for 2012. Gross profit came to DKK -10,987,566, and the net result was DKK -11,767,871.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of biomee ApS.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of biomee ApS.
On December 17, 2008, the company changed its name from TOXICELL ApS to DRUG DELIVERY SOLUTIONS ApS.
As of December 18, 2006, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of biomee ApS.
As of December 18, 2006, Jesper Jørn Lange is registered as director of biomee ApS.
Biomee ApS was founded on December 18, 2006.
Companies in the same industry and area
CVR 31591414
CVR 29312206
CVR 32551475
CVR 38892304
CVR 29519099
companydata.dk